DAVID syndrome
DAVID syndrome (Deficient Anterior pituitary with Variable Immune Deficiency) is a rare genetic disorder characterized by a combination of endocrine and immune system abnormalities. The syndrome is named after the key features of the condition: deficiencies in the anterior pituitary gland and variable immune deficiencies.
Clinical Features
Individuals with DAVID syndrome typically present with a range of symptoms due to the dysfunction of the anterior pituitary gland and the immune system. Common clinical features include:
- Growth hormone deficiency
- Adrenocorticotropic hormone deficiency
- Hypothyroidism
- Hypogonadism
- Recurrent infections due to immune deficiency
- Hypoglycemia
Genetics
DAVID syndrome is often caused by mutations in genes that are crucial for the development and function of the anterior pituitary gland and the immune system. The specific genetic mutations associated with DAVID syndrome can vary, leading to the variability in clinical presentation.
Diagnosis
The diagnosis of DAVID syndrome is based on clinical evaluation, hormone testing, and genetic testing. Key diagnostic criteria include:
- Hormone levels indicating anterior pituitary deficiencies
- Immune function tests showing variable immune deficiencies
- Genetic testing to identify causative mutations
Treatment
Treatment for DAVID syndrome is multidisciplinary and typically involves:
- Hormone replacement therapy to address deficiencies in growth hormone, adrenocorticotropic hormone, thyroid hormone, and sex hormones
- Immune system support, which may include immunoglobulin replacement therapy and prophylactic antibiotics to prevent infections
- Regular monitoring and management of associated complications
Prognosis
The prognosis for individuals with DAVID syndrome varies depending on the severity of the hormone deficiencies and immune dysfunction. With appropriate treatment and management, many individuals can lead relatively normal lives, although they may require lifelong medical care.
Related Pages
- Growth hormone deficiency
- Adrenocorticotropic hormone
- Hypothyroidism
- Hypogonadism
- Hypoglycemia
- Immune deficiency
See Also

This article is a genetic disorder stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian